Bioxcel therapeutics to participate in the jefferies virtual london healthcare conference

New haven, conn., nov. 13, 2020 (globe newswire) -- bioxcel therapeutics, inc. (“bti” or the “company”) (nasdaq: btai), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology, today announced that dr. vimal mehta, founder and chief executive officer of bti, will participate in a fireside chat at the jefferies virtual london healthcare conference.
BTAI Ratings Summary
BTAI Quant Ranking